Zika Virus Testing Market Size (2024 - 2029)

The Zika Virus Testing Market is projected to experience growth over the forecast period, driven by factors such as the increasing prevalence of Zika virus infections and advancements in testing technologies. The market's expansion is influenced by the heightened demand for testing during the COVID-19 pandemic, as the similarities between Zika and COVID-19 infections prompted increased diagnostic efforts. Government initiatives aimed at controlling the transmission of the Zika virus further contribute to market growth. Despite these positive trends, the high cost of testing kits poses a challenge to the market's expansion.

Market Size of Zika Virus Testing Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Zika Virus Testing Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 222.42 Million
Market Size (2029) USD 320.07 Million
CAGR (2024 - 2029) 7.55 %
Fastest Growing Market North America
Largest Market Asia-Pacific

Major Players

Zika Virus Testing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Zika Virus Testing Market Analysis

The Zika Virus Testing Market size is estimated at USD 222.42 million in 2024, and is expected to reach USD 320.07 million by 2029, growing at a CAGR of 7.55% during the forecast period (2024-2029).

COVID-19 significantly impacted the zika virus testing market during the forecast period. The spread of infectious diseases increased with the rising prevalence of coronavirus; hence, the demand for testing to diagnose the zika virus also increased during the pandemic. An NCBI study published in October 2021 showed that Zika infection closely resembles COVID-19 and other arboviral infections and stated that there was a considerable risk of Zika Virus Disease spreading across the world, which is especially dangerous in the backdrop of the COVID-19 virus outbreak. Thus, public health measures, vector control, and early diagnosis, especially in the case of pregnant women, are suggested during the pandemic in India to control the spread of the disease. Hence, the similar nature of infection of both the COVID-19 and Zika virus led to an increasing zika virus testing for diagnosis purposes globally, thereby impacting the growth of the market during the pandemic period. Also, the rising focus on the Zika virus diagnosis during the post-pandemic period is expected to contribute to the market's growth over the forecast period.

Factors such as the increasing prevalence of zika virus infection and technological advancements in zika virus testing are the major factors driving the growth of the market studied. As per the WHO data in October 2022, Zika virus (ZIKV) infection has been known to be endemic in Africa and Southeast Asia. The consequent viral spread over the Pacific region led to an outbreak in the developed and emerging countries. In addition, there have been major outbreaks of Zika virus infection in Asia-Pacific (particularly India) and South American countries. Also, the WHO data updated in February 2022 stated that Zika transmission persists in several countries but is most common at low levels till 2021. Thus, the rising prevalence of Zika virus infection is one of the primary factors driving the market's growth over the forecast period.

The other prominent drivers of the market studied are increasing research and development by biopharmaceutical companies and technological advancements in diagnostic tests. On the Other hand, governments worldwide are focusing more on initiatives to halt zika virus transmission is driving the studied market growth. For instance, in May 2022, the government of Uttar Pradesh (India) launched the 'Zero Mission' 'Zero to eradicate vector-borne diseases such as Japanese encephalitis, dengue, malaria, typhoid, pneumonia, and Zika virus. Thus, the rising prevalence of Zika virus infection worldwide and government initiatives are among the primary factors driving the market's growth over the forecast period.

However, the excessive cost of testing kits is predicted to hinder market growth in the forecast period.

Zika Virus Testing Industry Segmentation

As per the scope of the report, the Zika virus test is usually a blood test or a urine test, where the physician or other healthcare provider will take a blood sample from a vein in the patient's arm using a small needle.

The Zika Virus Testing Market is segmented by Test Type (Molecular Test and Serologic Test), End-User (Hospital/Clinic, Diagnostics Laboratory and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD million) for the above segments.

By Test Type
Molecular Test
Serologic Test
By End User
Hospital/Clinic
Diagnostics Laboratory
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Zika Virus Testing Market Size Summary

The Zika Virus Testing Market is poised for significant growth over the forecast period, driven by the increasing prevalence of Zika virus infections and advancements in diagnostic technologies. The market's expansion is influenced by the rising demand for effective testing solutions, particularly in regions where the virus is endemic, such as Africa, Southeast Asia, and the Asia-Pacific. The COVID-19 pandemic has also played a role in amplifying the demand for Zika virus testing, as the similarities in symptoms between Zika and COVID-19 heightened the need for accurate diagnosis. Public health initiatives and government efforts to control the spread of the virus further contribute to the market's growth, with countries like India implementing programs to eradicate vector-borne diseases, including Zika.

Technological advancements, particularly in molecular testing, are expected to bolster the market's growth. The development of innovative diagnostic platforms, such as those utilizing synthetic biology tools, offers promising solutions for rapid and decentralized testing. The molecular testing segment is anticipated to witness substantial growth due to increased research and development activities, as well as strategic partnerships and acquisitions by key market players. The competitive landscape is characterized by the presence of major companies like Abbott, F. Hoffmann-La Roche Ltd, and Siemens Healthcare GmbH, which are actively engaging in product launches and collaborations to enhance their diagnostic offerings. Despite challenges such as the high cost of testing kits, the market is expected to thrive, particularly in the Asia-Pacific region, where the prevalence of Zika virus infections remains a significant concern.

Explore More

Zika Virus Testing Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Zika Virus Infection

      2. 1.2.2 Increasing R&D by Biopharmaceutical Companies

      3. 1.2.3 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 Excessive Cost of Testing Kits

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Test Type

      1. 2.1.1 Molecular Test

      2. 2.1.2 Serologic Test

    2. 2.2 By End User

      1. 2.2.1 Hospital/Clinic

      2. 2.2.2 Diagnostics Laboratory

      3. 2.2.3 Others

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Zika Virus Testing Market Size FAQs

The Zika Virus Testing Market size is expected to reach USD 222.42 million in 2024 and grow at a CAGR of 7.55% to reach USD 320.07 million by 2029.

In 2024, the Zika Virus Testing Market size is expected to reach USD 222.42 million.

Zika Virus Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)